
    
      The goal of the PROMISE research study is to determine clinical/genomic alterations present
      in individuals with MGUS and SMM, who are diagnosed though screening of a high-risk
      population. We also seek to determine clinical/genomic/epigenetic and immune environmental
      predictors of progression to multiple myeloma in patients with MGUS and SMM.
    
  